Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 28, 2020
Gilead Sciences and Immunomedics have entered into a definitive agreement pursuant to which Gilead will acquire Immunomedics for $88.00 per share in cash.
read more
Cambrex announced the completion of initial engineering studies for its new, large-scale active pharmaceutical ingredient (API) manufacturing plant in Charles City, Iowa.
read more
Thursday, February 19, 2015
Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world at Clinical Trial Supply Europe, February 25-26 in Cannes,...
read more
Wednesday, April 06, 2016
Pfizer has announced that the merger agreement between Pfizer and Allergan has been terminated by mutual agreement of the companies. The decision was driven by the actions announced by the U.S. Department of Treasury on April 4, 2016, which the ...
read more
Regeneron and Zai Lab announced a collaboration for the development and commercialization of REGN1979 in mainland China, Hong Kong, Taiwan and Macau.
read more
Medidata, a Dassault Systèmes company, today announced that Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, is using Medidata to standardize its clinical trial platform for building out...
read more
NeoGenomics, a provider of cancer-focused genetic testing services, announced today that it has completed the acquisition of Clarient, Inc. and its wholly-owned subsidiary Clarient Diagnostic Services, Inc. Clarient, a provider of comprehensive ...
read more
Tuesday, January 30, 2018
Cambrex announced an investment to expand chemical and analytical development capabilities at its Charles City, Iowa plant.
read more
Wednesday, February 28, 2018
Catalent Pharma Solutions announced the completion of a two-year, $4.6 million expansion at its Singapore clinical supply facility.
read more
Wednesday, August 17, 2022
ProBioGen closed a Master Service Agreement with NextPoint and initiated development and GMP manufacturing of their lead antibody candidate.
read more
Wednesday, August 09, 2023
Regeneron Pharmaceuticals and Decibel Therapeutics announced a definitive agreement for the acquisition of Decibel by Regeneron at a price of $4.00 per share of Decibel common stock payable in cash at closing, with an additional non-tradeable ...
read more
Thursday, January 25, 2024
Sterling Pharma Solutions, a global contract development and manufacturing organization, announced the results of a pilot project to assess the use of new, ultra-low charge ammonia chilling technology.
read more
STA Pharmaceutical announce a strategic partnership.
read more
Grand River Aseptic Manufacturing ("GRAM"), a leading parenteral contract development and manufacturing organization, was recently ranked in Inc. Magazine's Inc. 5000 list for the third consecutive year.
read more
Monday, December 28, 2015
GlaxoSmithKline has announced the completion of its transaction to divest its rights to ofatumumab for auto-immune indications to Novartis Pharma AG, a subsidiary of Novartis AG, following regulatory approval.
read more